What is it prescribed for? DATROWAY™ is used to treat adults with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer who have already received endocrine-based therapy and chemotherapy​. Datroway was Approved by the FDA on January 17 2025 What is the name of the drug and what does it do?...
